|
| Press Releases |
|
 |
|
| Tuesday, October 19, 2021 |
|
|
Avance Clinical Client News: XWPharma Initiates First-in-Human Studies of XW10508, in Development for Fast-acting Relief of Treatment-Resistant Depression and Chronic Pain |
| Avance Clinical, the largest premium Australian CRO for international biotechs, is pleased to share the news that its client XWPharma Ltd. has announced dosing of subjects in its first-in-human study evaluating XW10508, the Company's novel, patented, glutamatergic NMDA antagonist and AMPA activator in development as an oral, once-daily therapy for the treatment of treatment-resistant depression and chronic pain. more info >> |
|
| Tuesday, August 10, 2021 |
|
|
Avance Clinical Awarded Frost & Sullivan 2021 Asia-Pacific CRO Best Practices Award for Customer Value Leadership |
| Avance Clinical, the largest premium Australian CRO for international biotechs, has been awarded the prestigious Frost & Sullivan 2021 Asia-Pacific CRO Customer Value Leadership Award, the second consecutive Asia-Pacific (APAC) CRO Best Practices Award for the company from Frost & Sullivan. more info >> |
|
| Friday, July 9, 2021 |
|
|
Avance Clinical Congratulates Client Tetherex Pharmaceuticals on Initiation of Dosing in a Phase 1 Clinical Study Using a Novel Single-Cycle Adenovirus Vaccine Strategy in Australia |
| The largest Australian full-service CRO for international biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical today congratulated client Tetherex Pharmaceuticals on first patient dosing for its Phase 1 vaccine clinical trial. more info >> |
|
| Monday, June 28, 2021 |
|
|
Avance Clinical Appoints Asia Biotech Specialist to Support APAC Growth |
| The leading Australian CRO for international biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical today announced the appointment of APAC expert Andy Hu as Business Development Manager APAC to support increasing biotech clinical trial demand from the region. more info >> |
|
| Friday, June 4, 2021 |
|
|
Avance Clinical's USA Biotech Survey Finds 21% Not Aware Australian Clinical Data is Accepted by the FDA and Other Major Regulatory Authorities |
| The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical announced the results of their Australian Clinical Trials Knowledge Survey with Endpoints News as part of their presence at BIO Digital 2021. more info >> |
|
| Thursday, May 27, 2021 |
|
|
Avance Clinical Releases Industry Survey Results at BIO Korea 2021 |
| The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical shared results of a recent industry survey conducted by the company that found data quality to be the most important criteria for selecting a CRO for Phase ll studies in Australia. more info >> |
|
| Friday, May 7, 2021 |
|
|
Avance Clinical Expands Gene Technology Clinical Trial Services to Meet $17.4 billion Market Demand |
| The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner, Avance Clinical, has expanded its gene technology clinical trial services to meet the increasing global demand predicted to reach $17.4 billion by 2023. more info >> |
|
| Thursday, April 22, 2021 |
|
|
Avance Clinical Invited to Present "Decentralized Trials - No Going Back" for Oracle Health Sciences Connect |
| The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical has been invited to present on the future of decentralized clinical trials at the Oracle Health Sciences Connect conference. more info >> |
|
| Friday, March 12, 2021 |
|
|
Avance Clinical Client Atossa Therapeutics Announces Final Results from Phase 1 Clinical Study Showing Safety and Tolerability of AT-301 Nasal Spray Being Developed for COVID-19 |
| The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical congratulated Atossa Therapeutics on the announcement of their Phase 1 final results for the AT-301 nasal spray being developed for COVID-19. more info >> |
|
| Friday, February 26, 2021 |
|
|
Avance Clinical and Medidata Celebrate Strategic Partnership and Inhouse Expert Accreditation Milestones |
| The leading Australian CRO for biotechs, and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner, Avance Clinical continues to celebrate their strategic partnership with Medidata, and the accreditation of seven Medidata inhouse experts. more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
TANAKA PRECIOUS METAL TECHNOLOGIES Develops Miniaturized Micro Profile, a Next-Generation Contact tape for Fifth-Generation Signal Relays
Mar 12, 2025 11:00 JST
|
|
|
JCB Now Available on Google Play in Thailand, Indonesia, Vietnam, Philippines, and Hong Kong
Mar 12, 2025 11:00 JST
|
|
|
Bear Robotics' Carti 100 Wins iF DESIGN AWARD 2025, Setting New Standards in Logistics Automation
Mar 11, 2025 23:58 HKT/SGT
|
|
|
Formerra Introduces Formerra+ Upgraded Ecommerce Site to Optimize Customer Experience
Mar 11, 2025 22:15 HKT/SGT
|
|
|
135 Years of Sport Inspiration: U.S. Polo Assn. Hosts Celebration Cup Exhibition and Spring-Summer 2025 Fashion Showcase in Delhi
Mar 11, 2025 20:00 HKT/SGT
|
|
|
2024 Results of Qunabox Group Released: Leading AI Interactive Marketing with Strong Revenue and Profit Growth
Mar 11, 2025 17:50 HKT/SGT
|
|
|
JCB Announced Premier Sponsorship for the 10th Edition of Sakura 2025 at Singapore's Gardens by the Bay 
Mar 11, 2025 18:00 JST
|
|
|
Hitachi Energy invests additional $250 million USD to address global transformer shortage
Mar 11, 2025 17:49 JST
|
|
|
Salary Reality Gap: 52% of Malaysian Employees See Scope for Salary Growth, foundit Survey Reveals
Mar 11, 2025 11:37 HKT/SGT
|
|
|
APEL Products Shine on the World Stage:Redefining Health and Sustainability - A Roadmap to Transformative Impact
Mar 10, 2025 21:22 HKT/SGT
|
|
|
Eisai Recognized as "2025 Kenko Investment for Health" for the First Time and Certified as "Outstanding Organization Of Kenko Investment for Health Program (White 500)" for the Sixth Time
Mar 10, 2025 20:24 JST
|
|
|
Entertainment Expo makes grand return
Mar 10, 2025 19:08 HKT/SGT
|
|
|
Hong Kong products highly rated by ASEAN e-shoppers
Mar 10, 2025 18:35 HKT/SGT
|
|
|
The New Economics of Power Markets in a Low-Carbon World 2025
Mar 10, 2025 18:20 HKT/SGT
|
|
|
CITIC Telecom CPC Wins Outstanding Award at 2025 Hong Kong Sustainable Development Innovation and Technology Awards
Mar 10, 2025 17:44 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
